This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Effects of combined cannabidiol (CBD) and hops (Humulus lupulus) terpene extract treatment on RAW 264.7 macrophage viability and inflammatory markers
Natural Products and Bioprospecting Open Access 07 June 2023
-
Pimecrolimus interferes the therapeutic efficacy of human mesenchymal stem cells in atopic dermatitis by regulating NFAT-COX2 signaling
Stem Cell Research & Therapy Open Access 28 August 2021
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Related links
PowerPoint slides
Rights and permissions
About this article
Cite this article
Pantazi, E., Valenza, G., Hess, M. et al. The atopic dermatitis market. Nat Rev Drug Discov 17, 237–238 (2018). https://doi.org/10.1038/nrd.2017.192
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd.2017.192
This article is cited by
-
Effects of combined cannabidiol (CBD) and hops (Humulus lupulus) terpene extract treatment on RAW 264.7 macrophage viability and inflammatory markers
Natural Products and Bioprospecting (2023)
-
Carboranes in drug discovery, chemical biology and molecular imaging
Nature Reviews Chemistry (2022)
-
Pimecrolimus interferes the therapeutic efficacy of human mesenchymal stem cells in atopic dermatitis by regulating NFAT-COX2 signaling
Stem Cell Research & Therapy (2021)
-
Atopic dermatitis
Nature Reviews Disease Primers (2018)